Schedule 13G ownership disclosure

Aytu BioPharma Inc

Common Stock, par value $0.0001 per share · CUSIP: 054754858

Event date: 2025-05-15

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Philotimo Fund, LP

    Shares: 425,500.00 · Class: 6.9%

  • Philotimo Focused Growth & Income Fund

    Shares: 209,573.00 · Class: 3.4%

  • Kanen Wealth Management LLC

    Shares: 635,073.00 · Class: 10.3%

  • Kanen David

    Shares: 635,073.00 · Class: 10.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000921895-25-001845
Form type
SCHEDULE 13G/A
Filer
AYTU BIOPHARMA, INC
CIK
CIK 1385818
Filed
Jun 26, 2025
Reporting period
May 15, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub